Annex I
United Kingdom
Pursuant to paragraph 3 of Decision XII/2 of the Twelfth Meeting of the Parties to the Montreal Protocol on measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (MDIs), the following countries have determined that, due to the presence of suitable non-CFC MDIs, CFCs no longer qualify as ‘essential’ under the Protocol when combined with following active ingredients:
LIST OF NON-ESSENTIAL SUBSTANCES
| Table 1 | |||||||||||
| Short-acting beta agonist bronchodilators | |||||||||||
| Country | Salbutamol | Terbutaline | Fenoterol | Orciprenaline | Reproterol | Carbuterol | Hexoprenaline | Pirbuterol | Clenbuterol | Bitolterol | Procaterol |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Austria | X | X | X | X | X | X | X | X | X | X | X |
| Belgium | X | X | X | X | X | X | X | X | X | X | X |
| Bulgaria | X | X | X | X | X | X | X | X | X | X | X |
| Cyprus | X | X | X | X | X | X | X | X | X | X | X |
| Czech Republic | X | X | X | X | X | X | X | X | X | X | X |
| Denmark | X | X | X | X | X | X | X | X | X | X | X |
| Estonia | X | X | X | X | X | X | X | X | X | X | X |
| Finland | X | X | X | X | X | X | X | X | X | X | X |
| France | X | X | X | X | X | X | X | X | X | X | X |
| Germany | X | X | X | X | X | X | X | X | X | X | X |
| Greece | X | X | X | X | X | X | X | X | X | X | X |
| Hungary | X | X | X | X | X | X | X | X | X | X | X |
| Ireland | X | X | X | X | X | X | X | X | X | X | X |
| Italy | X | X | X | X | X | X | X | X | X | X | X |
| Latvia | X | X | X | X | X | X | X | X | X | X | X |
| Lithuania | X | X | X | X | X | X | X | X | X | X | X |
| Luxembourg | X | X | X | X | X | X | X | X | X | X | X |
| Malta | X | X | X | X | X | X | X | X | X | X | X |
| Netherlands | X | X | X | X | X | X | X | X | X | X | X |
| Poland | X | X | X | X | X | X | X | X | X | X | X |
| Portugal | X | X | X | X | X | X | X | X | X | X | X |
| Romania | X | X | X | X | X | X | X | X | X | X | X |
| Slovakia | X | X | X | X | X | X | X | X | X | X | X |
| Slovenia | X | X | X | X | X | X | X | X | X | X | X |
| Spain | X | X | X | X | X | X | X | X | X | X | X |
| Sweden | X | X | X | X | X | X | X | X | X | X | X |
| United Kingdom | X | X | X | X | X | X | X | X | X | X | X |
| Table 2 | ||||||
| Inhaled steroids | ||||||
| Country | Beclomethasone | Dexamethasone | Flunisolide | Fluticasone | Budesonide | Triamcinolone |
|---|---|---|---|---|---|---|
| Austria | X | X | X | X | X | X |
| Belgium | X | X | X | X | X | X |
| Bulgaria | X | X | X | X | X | X |
| Cyprus | ||||||
| Czech Republic | X | X | X | X | X | X |
| Denmark | X | X | ||||
| Estonia | X | X | X | X | X | X |
| Finland | X | X | ||||
| France | X | X | ||||
| Germany | X | X | X | X | X | X |
| Greece | X | X | X | X | X | |
| Hungary | X | X | X | X | X | X |
| Ireland | X | X | ||||
| Italy | X | X | X | X | X | X |
| Latvia | X | X | X | X | X | X |
| Lithuania | X | X | X | X | X | X |
| Luxembourg | X | X | X | X | X | X |
| Malta | X | X | ||||
| Netherlands | X | X | X | X | X | X |
| Poland | X | X | X | X | X | X |
| Portugal | X | X | X | X | X | X |
| Romania | X | X | X | X | X | X |
| Slovakia | X | X | X | X | X | X |
| Slovenia | X | X | X | X | X | X |
| Spain | X | X | X | |||
| Sweden | X | X | ||||
| United Kingdom | X | |||||
| Table 3 | ||||||
| Non-steroidal anti-inflammatories | ||||||
| Country | Cromoglicic acid | Nedrocromil | ||||
|---|---|---|---|---|---|---|
| Austria | X | X | ||||
| Belgium | X | X | ||||
| Bulgaria | X | X | ||||
| Cyprus | X | X | ||||
| Czech Republic | X | X | ||||
| Denmark | X | X | ||||
| Estonia | X | X | ||||
| Finland | X | X | ||||
| France | X | X | ||||
| Germany | X | X | ||||
| Greece | X | X | ||||
| Hungary | X | |||||
| Ireland | ||||||
| Italy | X | X | ||||
| Latvia | X | X | ||||
| Lithuania | X | X | ||||
| Luxembourg | X | |||||
| Malta | X | |||||
| Netherlands | X | X | ||||
| Poland | X | X | ||||
| Portugal | X | |||||
| Romania | X | X | ||||
| Slovakia | X | X | ||||
| Slovenia | X | X | ||||
| Spain | X | |||||
| Sweden | X | X | ||||
| United Kingdom | X | X | ||||
| Table 4 | ||||||
| Anticholinergic bronchodilators | ||||||
| Country | Ipratropium bromide | Oxitropium bromide | ||||
|---|---|---|---|---|---|---|
| Austria | X | X | ||||
| Belgium | X | X | ||||
| Bulgaria | X | X | ||||
| Cyprus | X | X | ||||
| Czech Republic | X | X | ||||
| Denmark | X | X | ||||
| Estonia | X | X | ||||
| Finland | X | X | ||||
| France | ||||||
| Germany | X | X | ||||
| Greece | X | X | ||||
| Hungary | X | X | ||||
| Ireland | X | X | ||||
| Italy | ||||||
| Latvia | X | X | ||||
| Lithuania | X | X | ||||
| Luxembourg | X | X | ||||
| Malta | X | X | ||||
| Netherlands | X | X | ||||
| Poland | X | X | ||||
| Portugal | X | |||||
| Romania | X | X | ||||
| Slovakia | X | X | ||||
| Slovenia | X | X | ||||
| Spain | X | X | ||||
| Sweden | X | X | ||||
| United Kingdom | X | X | ||||
| Table 5 | ||||||
| Long-acting beta agonist bronchodilators | ||||||
| Country | Formoterol | Salmeterol | ||||
|---|---|---|---|---|---|---|
| Austria | X | X | ||||
| Belgium | X | X | ||||
| Bulgaria | X | X | ||||
| Cyprus | X | |||||
| Czech Republic | X | X | ||||
| Denmark | X | |||||
| Estonia | X | X | ||||
| Finland | X | X | ||||
| France | X | X | ||||
| Germany | X | X | ||||
| Greece | ||||||
| Hungary | X | X | ||||
| Ireland | X | X | ||||
| Italy | X | X | ||||
| Latvia | X | X | ||||
| Lithuania | X | X | ||||
| Luxembourg | X | X | ||||
| Malta | X | X | ||||
| Netherlands | X | X | ||||
| Poland | X | X | ||||
| Portugal | X | X | ||||
| Romania | X | X | ||||
| Slovakia | X | X | ||||
| Slovenia | X | X | ||||
| Spain | X | |||||
| Sweden | X | X | ||||
| United Kingdom | X | X | ||||
| Table 6 | ||||||
| Combinations of active ingredients in a single MDI | ||||||
| Country | ||||||
|---|---|---|---|---|---|---|
| Austria | X All products | |||||
| Belgium | X All products | |||||
| Bulgaria | X All products | |||||
| Cyprus | ||||||
| Czech Republic | X All products | |||||
| Denmark | X All products | |||||
| Estonia | ||||||
| Finland | X All products | |||||
| France | X All products | |||||
| Germany | X All products | |||||
| Greece | X All products | |||||
| Hungary | X All products | |||||
| Ireland | ||||||
| Italy | Budesonide + Fenoterol | Fluticasone+ Salmeterol | ||||
| Latvia | X All products | |||||
| Lithuania | X All products | |||||
| Luxembourg | X All products | |||||
| Malta | X All products | |||||
| Netherlands | X All products | |||||
| Poland | X All products | |||||
| Portugal | X All products | |||||
| Romania | X All products | |||||
| Slovakia | X All products | |||||
| Slovenia | X All products | |||||
| Spain | ||||||
| Sweden | X All products | |||||
| United Kingdom | ||||||